Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
Abroad (travel likely)RecruitingPHASE3
Conditions
Asthma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
China-Japan Friendship Hospital, Beijing, Chaoyang District, China
China-Japan Friendship Hospital, Beijing, Chaoyang District, China
Contact: Study coordinator (Chen Wang, Academician)
Study leads
Chen Wang Academician, Principal Investigator
Principal Investigator
China-Japan Friendship Hospital